IBDEI34R ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,49993,0)
 ;;=L03.012^^193^2487^103
 ;;^UTILITY(U,$J,358.3,49993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49993,1,3,0)
 ;;=3^Cellulitis of Left Finger
 ;;^UTILITY(U,$J,358.3,49993,1,4,0)
 ;;=4^L03.012
 ;;^UTILITY(U,$J,358.3,49993,2)
 ;;=^5009020
 ;;^UTILITY(U,$J,358.3,49994,0)
 ;;=L03.021^^193^2487^25
 ;;^UTILITY(U,$J,358.3,49994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49994,1,3,0)
 ;;=3^Acute Lymphangitis of Right Finger
 ;;^UTILITY(U,$J,358.3,49994,1,4,0)
 ;;=4^L03.021
 ;;^UTILITY(U,$J,358.3,49994,2)
 ;;=^5009022
 ;;^UTILITY(U,$J,358.3,49995,0)
 ;;=L03.022^^193^2487^19
 ;;^UTILITY(U,$J,358.3,49995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49995,1,3,0)
 ;;=3^Acute Lymphangitis of Left Finger
 ;;^UTILITY(U,$J,358.3,49995,1,4,0)
 ;;=4^L03.022
 ;;^UTILITY(U,$J,358.3,49995,2)
 ;;=^5009023
 ;;^UTILITY(U,$J,358.3,49996,0)
 ;;=L03.031^^193^2487^113
 ;;^UTILITY(U,$J,358.3,49996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49996,1,3,0)
 ;;=3^Cellulitis of Right Toe
 ;;^UTILITY(U,$J,358.3,49996,1,4,0)
 ;;=4^L03.031
 ;;^UTILITY(U,$J,358.3,49996,2)
 ;;=^5009025
 ;;^UTILITY(U,$J,358.3,49997,0)
 ;;=L03.032^^193^2487^106
 ;;^UTILITY(U,$J,358.3,49997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49997,1,3,0)
 ;;=3^Cellulitis of Left Toe
 ;;^UTILITY(U,$J,358.3,49997,1,4,0)
 ;;=4^L03.032
 ;;^UTILITY(U,$J,358.3,49997,2)
 ;;=^5009026
 ;;^UTILITY(U,$J,358.3,49998,0)
 ;;=L03.041^^193^2487^27
 ;;^UTILITY(U,$J,358.3,49998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49998,1,3,0)
 ;;=3^Acute Lymphangitis of Right Toe
 ;;^UTILITY(U,$J,358.3,49998,1,4,0)
 ;;=4^L03.041
 ;;^UTILITY(U,$J,358.3,49998,2)
 ;;=^5009028
 ;;^UTILITY(U,$J,358.3,49999,0)
 ;;=L03.042^^193^2487^21
 ;;^UTILITY(U,$J,358.3,49999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49999,1,3,0)
 ;;=3^Acute Lymphangitis of Left Toe
 ;;^UTILITY(U,$J,358.3,49999,1,4,0)
 ;;=4^L03.042
 ;;^UTILITY(U,$J,358.3,49999,2)
 ;;=^5009029
 ;;^UTILITY(U,$J,358.3,50000,0)
 ;;=M34.0^^193^2487^289
 ;;^UTILITY(U,$J,358.3,50000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50000,1,3,0)
 ;;=3^Progressive Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,50000,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,50000,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,50001,0)
 ;;=M34.1^^193^2487^92
 ;;^UTILITY(U,$J,358.3,50001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50001,1,3,0)
 ;;=3^CR(E)ST Syndrome
 ;;^UTILITY(U,$J,358.3,50001,1,4,0)
 ;;=4^M34.1
 ;;^UTILITY(U,$J,358.3,50001,2)
 ;;=^5011779
 ;;^UTILITY(U,$J,358.3,50002,0)
 ;;=M34.2^^193^2487^313
 ;;^UTILITY(U,$J,358.3,50002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50002,1,3,0)
 ;;=3^Systemic Sclerosis Induced by Drug/Chemical
 ;;^UTILITY(U,$J,358.3,50002,1,4,0)
 ;;=4^M34.2
 ;;^UTILITY(U,$J,358.3,50002,2)
 ;;=^5011780
 ;;^UTILITY(U,$J,358.3,50003,0)
 ;;=M34.81^^193^2487^315
 ;;^UTILITY(U,$J,358.3,50003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50003,1,3,0)
 ;;=3^Systemic Sclerosis w/ Lung Involvement
 ;;^UTILITY(U,$J,358.3,50003,1,4,0)
 ;;=4^M34.81
 ;;^UTILITY(U,$J,358.3,50003,2)
 ;;=^5011781
 ;;^UTILITY(U,$J,358.3,50004,0)
 ;;=M34.82^^193^2487^316
 ;;^UTILITY(U,$J,358.3,50004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50004,1,3,0)
 ;;=3^Systemic Sclerosis w/ Myopathy
 ;;^UTILITY(U,$J,358.3,50004,1,4,0)
 ;;=4^M34.82
 ;;^UTILITY(U,$J,358.3,50004,2)
 ;;=^5011782
 ;;^UTILITY(U,$J,358.3,50005,0)
 ;;=M34.83^^193^2487^317
